Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» labrolizumab
labrolizumab
Merck's Anti-PD1 Melanoma Drugs Shrinks Tumors In Half of Patients
The Street
Sun, 06/2/13 - 11:54 am
Merck
labrolizumab
melanoma